Abstract

This study was conducted to evaluate the chronic effects of eicosapentaenoic acid (EPA) on fatty acid and glucose metabolism in human skeletal muscle cells. Uptake of [14C]oleate was increased >2-fold after preincubation of myotubes with 0.6 mM EPA for 24 h, and incorporation into various lipid classes showed that cellular triacylgycerol (TAG) and phospholipids were increased 2- to 3-fold compared with control cells. After exposure to oleic acid (OA), TAG was increased 2-fold. Insulin (100 nM) further increased the incorporation of [14C]oleate into all lipid classes for EPA-treated myotubes. Fatty acid beta-oxidation was unchanged, and complete oxidation (CO2) decreased in EPA-treated cells. Basal glucose transport and oxidation (CO2) were increased 2-fold after EPA, and insulin (100 nM) stimulated glucose transport and oxidation similarly in control and EPA-treated myotubes, whereas these responses to insulin were abolished after OA treatment. Lower concentrations of EPA (0.1 mM) also increased fatty acid and glucose uptake. CD36/FAT (fatty acid transporter) mRNA expression was increased after EPA and OA treatment compared with control cells. Moreover, GLUT1 expression was increased 2.5-fold by EPA, whereas GLUT4 expression was unchanged, and activities of the mitogen-activated protein kinase p38 and extracellular signal-regulated kinase were decreased after treatment with OA compared with EPA. Together, our data show that chronic exposure of myotubes to EPA promotes increased uptake and oxidation of glucose despite a markedly increased fatty acid uptake and synthesis of complex lipids.

Highlights

  • This study was conducted to evaluate the chronic effects of eicosapentaenoic acid (EPA) on fatty acid and glucose metabolism in human skeletal muscle cells

  • oleic acid (OA) compared with EPA and the bovine serum albumin (BSA) control decreased the phosphorylation of both the extracellular signal-regulated kinase (ERK) and p38 mitogenactivated protein kinases (Fig. 6)

  • The present study shows that pretreatment of differentiated human myotubes with EPA promotes increased uptake and metabolism of [14C]oleate to cellular lipids, and the increased oleate uptake was not accompanied by increased [14C]oleate oxidation

Read more

Summary

EXPERIMENTAL PROCEDURES

Bovine serum albumin (essentially fatty acid-free), cytochalasin B, 2-deoxy-D-glucose, extracellular matrix gel, glycogen (rabbit liver), L-carnitine, and OA were purchased from SigmaAldrich (St. Louis, MO). L-Glutamine, 0.05% trypsin/EDTA, penicillin/streptomycin, fetal calf serum (FCS), and minimum essential medium a (aMEM) were purchased from Gibco (Paisley, UK). After 1–2 weeks at z80% confluence, growth medium was replaced by aMEM with 2% FCS, 50 U/ml penicillin, 50 mg/ml streptomycin, and 1.25 mg/ml amphotericin B to induce the differentiation of myoblasts into multinucleated myotubes. On day 7, differentiated myotubes were pretreated with 0.6 mM fatty acids, either OA or EPA, in aMEM with 2% FCS for 24 h. Myotubes were incubated on six-well plates for 4 h in aMEM with [1-14C]OA (0.5 mCi/ml, 0.6 mM) and 0.24 mM fatty acid-free albumin (BSA) with or without 100 nM insulin to study insulinmediated or basal cellular oleate distribution, respectively. Accession Number b-Actin Diacylglycerol acyltransferase-1 CD36/FAT (fatty acid transporter) Glucose transporter GLUT1 Glucose transporter GLUT4

F: ACC GAG CGC GGC TAC A R: TCC TTA ATG TCA CGC ACG ATT T F
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call